Effect of phenobarbital on hepatic eicosanoid concentrations in rats

Archives of Toxicology

Volumn 71, Issue 10, 1997, Pages 646-650

  Peebles, Rhonda S ^a   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Hepatocarcinogenesis; Leukotriene; Phenobarbital; Prostaglandin

Indexed keywords

ICOSANOID; LEUKOTRIENE; LEUKOTRIENE C4; PHENOBARBITAL; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER CARCINOGENESIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSANOIDS; HYPNOTICS AND SEDATIVES; LEUKOTRIENE C4; LIVER; MALE; MICROSOMES, LIVER; ORGAN SIZE; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES; TIME FACTORS;

ANIMALIA;

EID: 0030817672     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050439     Document Type: Article

References (30)

1. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167-170
2. Burke MD, Thompson S, Elcombe CL, Halpert J, Haaparanta T, Mayer RT (1985) Ethoxy-,pentoxy- and benzylophenoxanes and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34: 3337-3345
3. Cressman DE, Greenbaum LE, Haber BA, Taub R (1994) Rapid activation of post-hepatectomy factor nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 269: 30429-30435
4. Denda A, Ura H, Tsujiuchi T, Tsutsumi M, Eimoto H, Takashima Y, Kitazawa S, Kinugasa T, Konishi Y (1989) Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis. Carcinogenesis 10: 1929-1935
5. Denda A, Tang Q, Endoh T, Tsujiuchi T, Horiguchi K, Noguchi O, Mizumoto Y, Nakae D, Konishi Y (1994) Prevention by acetylsalicylic acid of liver cirrhosis and Carcinogenesis as well as generation of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis 15: 1279-1283
6. Fischer SM, Fürstenberger G, Marks F, Slaga TJ (1987) Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: a comparison between SENCAR and NMRI mice. Cancer Res 47: 3174-3179
7. Gill JL (1978) Design and analysis of experiments in the animal and medical sciences, vol 1, Iowa State University Press, Ames, Iowa
8. 2 in the liver of rats fed a choline deficient diet: possible involvement in liver tumor promotion. Cancer Lett 46: 129-135
9. 2α, glutathione-S-transferase activity, and oxidative stress. Prostaglandins Leukot Essent Fatty Acids 42: 45-50
10. Hong JT, Glauert HP (1996) Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes. J Cell Physiol 169: 309-319
11. Jirtle RL, Meyer SA (1991) Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transformation growth factor-β1 expression. Dig Dis Sci 36: 659-668
12. Kopp E, Ghosh S (1994) Inhibition of NF-κB by sodium salicylate and aspirin. Science 265: 956-959
13. Kuiper J, Casteleyn E, Van Berkel TJC (1988) Regulation of liver metabolism by intercellular communication. Adv Enzyme Regul 27: 193-208
14. Kunkel SL, Chensue SW, Phan SH (1986a) Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 136: 186-192
15. 2. Biochem Biophys Res Commun 137: 404-410
16. Lee PPH, Ip MM (1992) Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase. Prostaglandins Leukot Essent Fatty Acids 45: 21-31
17. Leung LK, Glauert HP (1996) Role of hepatic prostaglandins in the induction of DNA synthesis by phenobarbital and the peroxisome proliferator ciprofibrate in rats. Fundam Appl Toxicol 30: 132
18. Li YX, Leung LK, Spear BT, Glauert HP (1996) Activation of hepatic NF-kappa B by phenobarbital in rats. Biochem Biophys Res Commun 229: 982-989
19. Marnett LJ (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589
20. Okumura T, Kanemaki T, Kitade H (1993) Stimulation of glucose incorporation into glycogen by E-series prostaglandins in cultured rat hepatocytes. Biochim Biophys Acta 1176: 137-142
21. Pitot HC, Goldsworthy TL, Moran S, Kennan W, Glauert HP, Maronpot RR, Campbell HA (1987) A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 8: 1491-1499
22. Quiroga J, Prieto J (1993) Liver cytoprotection by prostaglandins Pharmacol Ther 58: 67-91
23. 2α: additivity with the effect of norepinephrine, and synergism with epidermal growth factor. J Cell Physiol 159: 35-40
24. Skouteris GG, Ord MG, Stocken LA (1988) Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J Cell Physiol 135: 516-520
25. Takahashi M, Furukawa F, Toyoda K, Sato H, Hasegawa R, Imaida K, Hayashi Y (1990) Effects of various prostaglandin synthesis inhibitors on pancreatic Carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 11: 393-395
26. Tang Q, Denda A, Tsujiuchi T, Tsutsumi M, Amanuma T, Murata Y, Maruyama H, Konishi Y (1993) Inhibitory effects of inhibitors of arachidonic acid metabolism on the evolution of rat liver preneoplastic foci into nodules and hepatocellular carcinomas with or without phenobarbital exposure. Jpn J Cancer Res 84: 120-127
27. 2 and rat liver regeneration. Gastroenterology 105: 495-499
28. Waxman DJ, Azaroff L (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281: 577-592
29. Wickremasinghe RG (1988) The role of prostaglandins in the regulation of cell proliferation. Prostaglandins Leukot Essent Fatty Acids 31: 171-179
30. Wilson MW, Lay LT, Chow CK, Tai HH, Robertson LW, Glauert HP (1995) Altered hepatic eicosanoid concentrations in rat treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Arch Toxicol 69: 491-497